While successful antiretroviral therapy means that more HIV-positive men are living into their senior years and subsequently facing increased risks for prostate cancer, the good news is that neither HIV infection nor antiretroviral drugs interfere with standard prostate cancer tests or treatments, scientists write in the British Journal of Urology. All HIVers with well-controlled HIV infections diagnosed with prostate cancer, the researchers say, should therefore be managed similarly to HIV-negative prostate cancer patients.
